Mounjaro (Tirzepatide) Injection 12.5 mg/0.5 mL Prefilled Syringes are prescription medications used to treat type 2 diabetes. They contain 12.5 mg of tirzepatide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist.

These syringes are pre-filled with a single dose of tirzepatide and are intended for subcutaneous injection (under the skin) once a week. They are used in combination with diet and exercise to help lower blood sugar levels in patients with type 2 diabetes.

Tirzepatide works by increasing insulin secretion, reducing glucagon (a hormone that raises blood sugar), and slowing down the emptying of food from the stomach, which helps to lower blood sugar levels after a meal. It may also help with weight loss in patients with diabetes.

Mounjaro (Tirzepatide) is a type of medication called a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is used to help improve blood sugar control in adults with type 2 diabetes.

Tirzepatide works by mimicking the action of two naturally occurring hormones in the body, GIP and GLP-1. Both of these hormones are involved in regulating blood sugar levels.

GLP-1 helps to increase insulin production and release from the pancreas, while decreasing the production of glucagon, a hormone that raises blood sugar levels. GIP also stimulates insulin production and release from the pancreas.

By activating both of these hormones, tirzepatide helps to lower blood sugar levels and improve insulin sensitivity, which can help to control diabetes.

Mounjaro (Tirzepatide) is administered as a subcutaneous injection once a week, and it is important to follow the dosing instructions provided by your healthcare provider. It is also important to continue following a healthy diet and exercise plan while taking tirzepatide to help manage diabetes.